Open an account

Gabelli Healthcare & WellnessRx Trust

GRX · NYSE

$9.96−$0.06 (−0.60%)TodayMarket closed ·
Prev close $10.02

About GRX

Gabelli Healthcare & WellnessRx Trust is a US-based company operating in industry. The company is headquartered in Rye, New York. The company went IPO on 2007-06-19. The Gabelli Healthcare and WellnessRx Trust (the Fund) is a non-diversified closed-end management investment company. The Fund’s investment objective is long term growth of capital. Under normal market conditions, the Fund will invest at least 80% of its net assets (plus borrowings made for investment purposes) in equity securities (such as common stock and preferred stock) and income producing securities (such as fixed income debt securities and securities convertible into common stock) of domestic and foreign companies in the healthcare and wellness industries. The company invests in various sector, such as beverages, biotechnology, electronics, equipment and supplies, food, health care providers and service, household and personal products, and pharmaceuticals. The Fund’s investment adviser is Gabelli Funds, LLC.

Employees
0
Headquarters
Rye, New York
Listed
Jun 19, 2007
Sector
N/A
Industry
N/A
Website
gabelli.com

GRX key statistics

Market cap
146.61M
Price-earnings ratio
65.92
Dividend yield
6.88%
Average volume
14.27K
Volume
19.82K
Open price
$9.96
High today
$10.00
Low today
$9.95
52 Week high
$10.20
52 Week low
$8.80

Gabelli Healthcare & WellnessRx Trust (GRX) at a glance

Gabelli Healthcare & WellnessRx Trust (GRX) last traded at $9.96, with a market cap of 146.61M, a price-to-earnings ratio of 65.92 and a dividend yield of 6.88%.

Today the stock has traded between $9.95 and $10.00. The current price is 0.1% above the day's low and 0.4% below its high.

Volume so far is 19.82K shares, above the average of 14.27K shares a day.

Over the past year Gabelli Healthcare & WellnessRx Trust has ranged from $8.80 to $10.20, and now sits 83% of the way up that range.

GRX news

  • European Capital Insights

    Europe's Antimony Dilemma: Geopolitics, Greenland, And Battle for Critical Mineral Supply

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.